120 related articles for article (PubMed ID: 7543440)
1. Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma.
Akmal SN; Yun K; MacLay J; Higami Y; Ikeda T
Hum Pathol; 1995 Aug; 26(8):846-51. PubMed ID: 7543440
[TBL] [Abstract][Full Text] [Related]
2. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
[TBL] [Abstract][Full Text] [Related]
3. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.
Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ
Exp Cell Res; 2001 Oct; 270(1):88-95. PubMed ID: 11597130
[TBL] [Abstract][Full Text] [Related]
4. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
5. Promoter-specific transcription of the IGF2 gene: a novel rapid, non-radioactive and highly sensitive protocol for mRNA analysis.
Hartmann W; Waha A; Koch A; Albrecht S; Gray SG; Ekström TJ; von Schweinitz D; Pietsch T
Virchows Arch; 2001 Dec; 439(6):803-7. PubMed ID: 11787854
[TBL] [Abstract][Full Text] [Related]
6. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
7. H19 and IGF-2 allele-specific expression in hepatoblastoma.
Ross JA; Radloff GA; Davies SM
Br J Cancer; 2000 Feb; 82(4):753-6. PubMed ID: 10732739
[TBL] [Abstract][Full Text] [Related]
8. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.
López-Terrada D; Gunaratne PH; Adesina AM; Pulliam J; Hoang DM; Nguyen Y; Mistretta TA; Margolin J; Finegold MJ
Hum Pathol; 2009 Jun; 40(6):783-94. PubMed ID: 19200579
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting in hepatoblastoma.
Rainier S; Dobry CJ; Feinberg AP
Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
[TBL] [Abstract][Full Text] [Related]
11. Expression levels of insulin-like growth factor binding proteins and insulin receptor isoforms in hepatoblastomas.
von Horn H; Tally M; Hall K; Eriksson T; Ekström TJ; Gray SG
Cancer Lett; 2001 Jan; 162(2):253-60. PubMed ID: 11146233
[TBL] [Abstract][Full Text] [Related]
12. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
[TBL] [Abstract][Full Text] [Related]
13. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
Fukuzawa R; Umezawa A; Ochi K; Urano F; Ikeda H; Hata J
Int J Cancer; 1999 Aug; 82(4):490-7. PubMed ID: 10404060
[TBL] [Abstract][Full Text] [Related]
14. In situ detection of insulin-like growth factor II (IGF2) and H19 gene expression in hepatocellular carcinoma.
Sohda T; Iwata K; Soejima H; Kamimura S; Shijo H; Yun K
J Hum Genet; 1998; 43(1):49-53. PubMed ID: 9609998
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level.
Sohda T; Yun K; Iwata K; Soejima H; Okumura M
Lab Invest; 1996 Sep; 75(3):307-11. PubMed ID: 8804354
[TBL] [Abstract][Full Text] [Related]
16. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma.
Montagna M; Menin C; Chieco-Bianchi L; D'Andrea E
J Cancer Res Clin Oncol; 1994; 120(12):732-6. PubMed ID: 7798299
[TBL] [Abstract][Full Text] [Related]
17. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
Albrecht S; von Schweinitz D; Waha A; Kraus JA; von Deimling A; Pietsch T
Cancer Res; 1994 Oct; 54(19):5041-4. PubMed ID: 7923113
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of members of the IGF-axis in hepatoblastomas.
Gray SG; Eriksson T; Ekström C; Holm S; von Schweinitz D; Kogner P; Sandstedt B; Pietsch T; Ekström TJ
Br J Cancer; 2000 May; 82(9):1561-7. PubMed ID: 10789725
[TBL] [Abstract][Full Text] [Related]
19. High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.
Weiss JBW; Wagner AE; Eberherr C; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
Cancer Biomark; 2020; 28(3):321-328. PubMed ID: 32390604
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I and II and insulin-like growth factor binding protein-2 RNAs are expressed in adjacent tissues within rat embryonic and fetal limbs.
Streck RD; Wood TL; Hsu MS; Pintar JE
Dev Biol; 1992 Jun; 151(2):586-96. PubMed ID: 1376289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
